Influenza
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout Influenza
Influenza is a approved stage product being developed by Novartis for Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT00311428. Target conditions include Influenza.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00311428 | Approved | Completed |
Competing Products
20 competing products in Influenza